These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9033470)

  • 21. A pilot study of corticosteroid priming for lymphoblastoid interferon alfa in patients with chronic hepatitis C.
    Chayama K; Tsubota A; Kobayashi M; Hashimoto M; Miyano Y; Koike H; Kobayashi M; Koida I; Arase Y; Saitoh S; Murashima N; Ikeda K; Kumada H
    Hepatology; 1996 May; 23(5):953-7. PubMed ID: 8621174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infection with hepatitis C virus genotype 4 is associated with a poor response to interferon-alpha.
    Zylberberg H; Chaix ML; Bréchot C
    Ann Intern Med; 2000 May; 132(10):845-6. PubMed ID: 10819720
    [No Abstract]   [Full Text] [Related]  

  • 23. Response to combined interferon and ribavirin is better in patients infected with hepatitis C virus genotype 6 than genotype 1 in Hong Kong.
    Yuen MF; Lai CL
    Intervirology; 2006; 49(1-2):96-8. PubMed ID: 16166796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occult hepatitis C: how convincing are the current data?
    Welker MW; Zeuzem S
    Hepatology; 2009 Feb; 49(2):665-75. PubMed ID: 19105211
    [No Abstract]   [Full Text] [Related]  

  • 25. Influence of hepatitis C virus (HCV) genotype, HCV RNA load, and alanine aminotransferase level on reduction of HCV RNA after a single administration of interferon-alpha.
    Antonelli G; Riva E; Maggi F; Vatteroni ML; Simeoni E
    J Infect Dis; 1999 Oct; 180(4):1411-2. PubMed ID: 10479188
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of non-A, non-B hepatitis with glycyrrhizin].
    Ohta W; Iwamura K
    Nihon Rinsho; 1988 Dec; 46(12):2681-8. PubMed ID: 3149342
    [No Abstract]   [Full Text] [Related]  

  • 27. Combined antiviral therapy for recurrent hepatitis C virus after liver transplantation.
    Fontana M; Ciuffreda D; Moradpour D; Pascual M
    Transplantation; 2007 Feb; 83(4):525-6. PubMed ID: 17318091
    [No Abstract]   [Full Text] [Related]  

  • 28. Histologic outcome of hepatitis C virus infection in renal transplant recipients and the effect of pretransplantation interferon treatment.
    Gürsoy M; Bilezikci B; Colak T; Köksal R; Demirhan B; Karavelioğlu D; Boyacioğlu S; Bilgin N; Arslan G
    Transplant Proc; 2000 May; 32(3):558-60. PubMed ID: 10812112
    [No Abstract]   [Full Text] [Related]  

  • 29. Therapy of hepatitis C: patients with normal aminotransferase levels.
    Marcellin P; Lévy S; Erlinger S
    Hepatology; 1997 Sep; 26(3 Suppl 1):133S-136S. PubMed ID: 9305678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of early interferon alfa therapy for hepatitis C virus infection recurrence after liver transplantation.
    Boillot O; Berger F; Rasolofo E; Mion F; Chevallier P; Gille D; Paliard P
    Transplant Proc; 1995 Aug; 27(4):2501. PubMed ID: 7544508
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of acute hepatitis C with interferon alfa-2b.
    Seligman HK; Fox RK
    N Engl J Med; 2002 Apr; 346(14):1091-2. PubMed ID: 11936120
    [No Abstract]   [Full Text] [Related]  

  • 32. [Chronic hepatitis C and interferon alpha treatment].
    Skarpetowski AC; Pawłowska J; Madaliński K
    Pediatr Pol; 1995 May; 70(5):413-25. PubMed ID: 8692596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Ribavirin treatment in patients with chronic hepatitis C refractory to interferon-alpha].
    Acero D; Adrados M; González-Huix F; Figa M
    Gastroenterol Hepatol; 1996 May; 19(5):243-6. PubMed ID: 8752565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of chronic hepatitis C.
    Reichard O
    Scand J Infect Dis Suppl; 1994; 95():1-56. PubMed ID: 7939437
    [No Abstract]   [Full Text] [Related]  

  • 35. Serial quantitation of serum core protein and viral RNA of hepatitis C virus after interferon therapy: increase in viral loads in biochemical responders.
    Yoshioka K; Aiyama T; Iwata K; Yano M; Okumura A; Ishikawa T; Kakumu S
    Am J Gastroenterol; 1997 Aug; 92(8):1305-9. PubMed ID: 9260795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of interferon alfa therapy in chronic hepatitis C patients depends primarily on hepatitis C virus RNA level.
    Yamada G; Takatani M; Kishi F; Takahashi M; Doi T; Tsuji T; Shin S; Tanno M; Urdea MS; Kolberg JA
    Hepatology; 1995 Nov; 22(5):1351-4. PubMed ID: 7590646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency of very low HCV viremia detected by a highly sensitive HCV-RNA assay.
    Fytili P; Tiemann C; Wang C; Schulz S; Schaffer S; Manns MP; Wedemeyer H
    J Clin Virol; 2007 Aug; 39(4):308-11. PubMed ID: 17625963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interfering with interferon: re-igniting the debate on calcineurin inhibitor choice and antiviral therapy for hepatitis C virus recurrence.
    Watashi K; Metselaar HJ; van der Laan LJ
    Liver Transpl; 2008 Mar; 14(3):265-7. PubMed ID: 18306373
    [No Abstract]   [Full Text] [Related]  

  • 39. [Evaluating the efficacy of interferon therapy on hepatitis C patients].
    Shiraha H; Iwasaki Y; Shiratori Y
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):489-92. PubMed ID: 15359847
    [No Abstract]   [Full Text] [Related]  

  • 40. Hepatitis C treatment gets into a new gear.
    Khokhar N
    J Coll Physicians Surg Pak; 2014 Dec; 24(12):879-81. PubMed ID: 25523720
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.